LENSAR Inc
NASDAQ:LNSR

Watchlist Manager
LENSAR Inc Logo
LENSAR Inc
NASDAQ:LNSR
Watchlist
Price: 8.69 USD 0.46%
Market Cap: 100.9m USD
Have any thoughts about
LENSAR Inc?
Write Note

LENSAR Inc
Investor Relations

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 110 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company has developed the LENSAR Laser System to provide an alternative laser cataract treatment tool that allows the surgeon to better address astigmatism and improve visual outcomes. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The company is also developing an integrated cataract treatment system, ALLY, which is designed to combine its existing femtosecond laser technology with phacoemulsification system into a single unit and allow surgeons to perform each of the critical steps in a cataract procedure in a single operating room using this device.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Nicholas T. Curtis
President, CEO & Director
No Bio Available
Mr. Thomas R. Staab II, CPA
CFO & Secretary
No Bio Available
Mr. Alan B. Connaughton
Chief Operating Officer
No Bio Available
Ms. Kendra W. Wong
Principal Accounting Officer
No Bio Available

Contacts

Address
FLORIDA
Orlando
2800 Discovery Drive, Suite 100
Contacts
+18885367271.0
www.lensar.com